These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11640907)

  • 1. Nicotine administration reduces striatal MPP+ levels in mice.
    Quik M; Di Monte DA
    Brain Res; 2001 Nov; 917(2):219-24. PubMed ID: 11640907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
    Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
    Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment.
    Irwin I; Finnegan KT; Delanney LE; Di Monte D; Langston JW
    Brain Res; 1992 Feb; 572(1-2):224-31. PubMed ID: 1611516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
    Quik M; Parameswaran N; McCallum SE; Bordia T; Bao S; McCormack A; Kim A; Tyndale RF; Langston JW; Di Monte DA
    J Neurochem; 2006 Sep; 98(6):1866-75. PubMed ID: 16882311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
    Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
    Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse.
    Sershen H; Hashim A; Wiener HL; Lajtha A
    Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice.
    Rojas P; Serrano-García N; Medina-Campos ON; Pedraza-Chaverri J; Maldonado PD; Ruiz-Sánchez E
    J Nutr Biochem; 2011 Oct; 22(10):937-44. PubMed ID: 21190833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
    Boireau A; Dubedat P; Bordier F; Imperato A; Moussaoui S
    Neuropharmacology; 2000 Apr; 39(6):1016-20. PubMed ID: 10727711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
    Johannessen JN
    Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress induced by MPTP and MPP(+): selective vulnerability of cultured mouse astrocytes.
    Wong SS; Li RH; Stadlin A
    Brain Res; 1999 Jul; 836(1-2):237-44. PubMed ID: 10415427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
    Mitsumoto Y; Mori A
    Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
    Singh S; Singh K; Patel S; Patel DK; Singh C; Nath C; Singh MP
    Brain Res; 2008 May; 1207():193-206. PubMed ID: 18374908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.